Collaboration will enable transparent, cGMP, and scalable manufacture of custom cell culture media Cytiva, a global life sciences leader, and Nucleus Biologics, LLC, The Cell Performance Company™, have signed a… Read More
Tony Wood to assume full accountability for GSK R&D in August 2022 Hal Barron to transition in August 2022 from CSO to a GSK Non-Executive Director with additional responsibilities to… Read More
CBT is the first of several rare cannabinoid launches planned for the first half of 2022; includes CBDV and THCV Expands the Company’s rare cannabinoid product portfolio, which also includes… Read More
The partnership gives Amplitude access to Alberta’s sizeable AI sector. Edmonton-based artificial intelligence (AI) company AltaML and Montréal health-focused Amplitude Ventures want to fuel more Canadian AI and biotech companies…. Read More
HOUSTON and VANCOUVER, BC – ESSA Pharma Inc. (NASDAQ: EPIX) (“ESSA” or the “Company”), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced the first patient… Read More
